Search Results - "MONNIER, L"

The application of simple metrics in the assessment of glycaemic variability by Monnier, L., Colette, C., Owens, D.R.

“…The assessment of glycaemic variability (GV) remains a subject of debate with many indices proposed to represent either short- (acute glucose fluctuations) or…”
Get full text

Statistical and clinical significances: Are they equivalent? by Monnier, L., Bonnet, F.

Get full text

Glycaemic variabilities: Key questions in pursuit of clarity by Monnier, L.ouis, Owens, David, Colette, Claude, Bonnet, Fabrice

“…After years of intensive investigation, the definition of glycaemic variability remains unclear and the term variability in glucose homoeostasis might be more…”
Get full text

Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications by Monnier, L, Colette, C

“…Abstract Both postprandial and fasting (basal) hyperglycaemia contribute to overall hyperglycaemia (ambient hyperglycaemia) in type 2 diabetes (T2D)…”
Get full text

Application of medium-term metrics for assessing glucose homoeostasis: Usefulness, strengths and weaknesses by Monnier, L., Colette, C., Owens, D.

“…This review aims to address the issue of whether or not the newer metrics, developed for continuous glucose monitoring [real-time CGM (rtCGM), intermittently…”
Get full text

Number Needed-to-Treat (NNT): Is it a necessary marker of therapeutic efficiency? by Monnier, L., Colette, C., Bonnet, F., Owens, D.

“…Therapeutic efficiency of Glucagon-Like Peptide-1 receptor agonists (GLP-1RAs) is generally assessed from Randomized Controlled Trials (RCTs) by comparing…”
Get full text

Assessing the Helium Potential of Variscan Batholiths: Insight From Corsica Island by Dutoit, H., Donzé, F. V., Cardoso, C., Charroy, J., Riba Pereyra, C., Taillefer, A., Dusséaux, C., Tisserand, D., Monnier, L., Byrdina, S., Pik, R., Truche, L.

“…Most of the current helium (He) reserves originate from fortuitous discoveries, mainly made during oil and gas exploration in sedimentary basins. As helium…”
Get full text

Calibration free continuous glucose monitoring (CGM) devices: Weighing up the benefits and limitations by Monnier, L., Colette, C., Owens, D.

“…Since the approval of the first continuous glucose-monitoring (CGM) device [1], CGM has been increasingly introduced to people with type 1 diabetes and to a…”
Get full text

Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy by Monnier, L, Colette, C, Mas, E, Michel, F, Cristol, J. P, Boegner, C, Owens, D. R

“…Aims/hypothesis We examined whether type of diabetes and/or insulin treatment can modulate the impact of sustained hyperglycaemia and glycaemic variability as…”
Get full text

Glucose variability: Do we have to revisit the profusion of definitions to avoid confusion? by Monnier, L., Colette, C., Owens, D.

Get full text

Glucocentric risk factors for macrovascular complications in diabetes: Glucose ‘legacy’ and ‘variability’-what we see, know and try to comprehend by Monnier, L., Colette, C., Schlienger, J.-L., Bauduceau, B., R Owens, D.

“…Recognizing the role of dysglycaemia, ‘ambient’ hyperglycaemia, ‘metabolic memory’ and glycaemic variability as risk factors for macrovascular diseases is…”
Get full text

Two phases of aging separated by the Smurf transition as a public path to death by Dambroise, E., Monnier, L., Ruisheng, L., Aguilaniu, H., Joly, J.-S., Tricoire, H., Rera, M.

“…Aging’s most obvious characteristic is the time dependent increase of an individual’s probability to die. This lifelong process is accompanied by a large…”
Get full text

Effect of standing frames used in real life on bone remodeling in non-walking children with cerebral palsy by Barbier, V., Goëb, V., Klein, C., Fritot, S., Mentaverri, R., Sobhy Danial, J., Fardellone, P., Le Monnier, L.

“…Summary Children with severe cerebral palsy are prone to low bone mineral density. No clear recommendation exists for an optimal use of standing frame to…”
Get full text

Residual dysglycemia when at target HbA1c of 7% (53 mmol/mol) in persons with type 2 diabetes by Monnier, L, Colette, C, Dejager, S, Owens, D

“…Abstract Aims To understand the composition of the residual dysglycemia when HbA1c is between 6.5% (48 mmol/mol) and 7% (53 mmol/mol), representing the…”
Get full text

A Prospective Multicenter Study of 163 Sleeve Gastrectomies: Results at 1 and 2 Years by Nocca, D., Krawczykowsky, D., Bomans, B., Noël, P., Picot, M. C., Blanc, P. M., de Seguin de Hons, C., Millat, B., Gagner, M., Monnier, L., Fabre, J. M.

“…Background Good results obtained after laparoscopic sleeve gastrectomy (LSG), in terms of weight loss and morbidity, have been reported in few recent studies…”
Get full text

Differential effects of GLP-1 receptor agonists on components of dysglycaemia in individuals with type 2 diabetes mellitus by Owens, D.R, Monnier, L, Bolli, G.B

“…Abstract Metabolic consequences of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are the result of enhanced glucose-stimulated insulin secretion,…”
Get full text

The dawn phenomenon in type 2 diabetes: How to assess it in clinical practice? by Monnier, L, Colette, C, Dejager, S, Owens, D

“…Abstract Aim The study was aimed at determining whether the dawn phenomenon in type 2 diabetes (T2D) can be predicted and quantified using simple and easily…”
Get full text

Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes by Colette, C, Monnier, L

“…Chronic hyperglycemia, usually assessed from HbA1c determinations, results in excessive glycation and generation of oxidative stress. As a consequence, chronic…”
Get more information

Insulin and atherosclerosis: How are they related? by Monnier, L, Hanefeld, M, Schnell, O, Colette, C, Owens, D

“…Abstract The relationship between insulin and atherosclerosis is complex. People with type 2 diabetes are affected by three main glycaemic disorders: chronic…”
Get full text

Glycaemic variability and ambient hyperglycaemia: How and when are they linked? by Monnier, L, Colette, C

Get full text